Subject: "Drug testing" / Collection: Joyner Federal Documents

Clear Search

You searched for: Subject "Drug testing" Collection Joyner Federal Documents

« Previous | 71 - 80 of 81 | Next »

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988
by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
1988
Format: Book and Print

✔ Available Joyner - Fed Docs Stacks

Call Number: Y 4.G 74/7:F 73/13

Why volunteer? : clinical trials of medical treatments
by United States. Food and Drug Administration
2001
Format: Book and Print

✔ Available Joyner - Fed Docs Stacks

Call Number: HE 20.4002:V 88

✔ Available Joyner - Fed Docs Stacks

Call Number: Y 4.G 74/7:F 73/11

✔ Available Joyner - Fed Docs Stacks

Call Number: Y 4.G 74/7:C 61/2

✔ Available Joyner - Fed Docs Stacks

Call Number: Y 4.G 74/7:D 84/24

✔ Available Joyner - Fed Docs Stacks

Call Number: ASK AT REFERENCE DESK

✔ Available Joyner - Fed Docs Stacks

Call Number: Y 4.EN 2/3:102-132

Guide for detecting fraud in bioresearch monitoring inspections
1993
Format: Book and Microform

✔ Available Joyner - Microforms B300

Call Number: HE 20.4008:F 86

✔ Available Joyner - Fed Docs Stacks

Call Number: Y 4.G 74/7:C 83/3

✔ Available View 2 Items

Library	Location	Call Number	Status
Joyner	Fed Docs Stacks	Y 4.IN 8/4:96-170	✔ Available
Joyner	Fed Docs Stacks	Y 4.IN 8/4:96-216	✔ Available

« Previous
Next »
1
2
…
4
5
6
7
8
9

Find materials by

Location

Format

Publication Date

Collection

Language

Genre

Region

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988

Why volunteer? : clinical trials of medical treatments

FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987

Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998

Therapeutic drugs for AIDS : development, testing, and availability : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, April 28 and 29, 1988

Addressing the FDA's performance, efficiency, and use of resources : hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... March 19 and April 11, 1997

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992

Guide for detecting fraud in bioresearch monitoring inspections

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...

ECU Libraries Catalog

Find materials by

Search Constraints

Search Results